PER 0.00% 10.0¢ percheron therapeutics limited

News: ANP Antisense Therapeutics says ATL1102 for MS Phase IIb IND submitted to FDA for review, page-26

  1. 11,041 Posts.
    lightbulb Created with Sketch. 985
    kp, keep in mind that all investors are not sheep and all sheep are not slaughtered. Pop those facts into your logical thinking. Add in the fact that this is a highly speculative field with many losers and a few monstrous winners. With a dash of good fortune we can make a nice profit. Those of us who are not sheep realise the speculative nature of this field and have only risked what we are prepared to lose on a long shot. I suspect that most of the grumbling negativity has come from people who have over invested in what always should have been treated as a long shot. Have a great day kp.

    Good fortune all ANP holders,
    Gatesy
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.